Financing

Companies in the biotech industry are highly dependent on funding in the form of equity, loans, and subsidies. Axon Lawyers has assisted many biotech companies in this field. Our advice comprises:

• Strategic advice on the most suitable form of financing, taking into account the phase of the company and the business model
• Equity financing: investment agreements, shareholder agreements, and stock options plans
• Subsidies and grants: drafting and/or reviewing of consortium agreements for subsidised research projects (FP7, Transbio, PiD, Eurostar, CTMM, TI Pharma, TTI GG, NanonextNL, etc.), advice on governmental support issues, and advice on terms for innovation credits and other governmental loans and grants
• Commercial loans: Commercial loan agreements (including BBMKB), security agreements (pledge, surety, etc.)